Financials data is unavailable for this security.
View more
Year on year KNC Laboratories Co Ltd 's net income fell -3.23% from 1.54bn to 1.49bn despite revenues that grew 6.10% from 8.63bn to 9.15bn. An increase in the cost of goods sold as a percentage of sales from 61.71% to 64.00% was a component in the falling net income despite rising revenues.
| Gross margin | 33.92% |
|---|---|
| Net profit margin | 14.38% |
| Operating margin | 20.02% |
| Return on assets | 8.05% |
|---|---|
| Return on equity | 10.13% |
| Return on investment | 8.86% |
More ▼
Cash flow in JPYView more
In 2024, KNC Laboratories Co Ltd increased its cash reserves by 44.15%, or 1.01bn. The company earned 3.20bn from its operations for a Cash Flow Margin of 35.00%. In addition the company generated 178.87m cash from financing while 2.37bn was spent on investing.
| Cash flow per share | 283.71 |
|---|---|
| Price/Cash flow per share | 4.14 |
| Book value per share | 1,686.42 |
|---|---|
| Tangible book value per share | 1,679.89 |
More ▼
Balance sheet in JPYView more
| Current ratio | 4.53 |
|---|---|
| Quick ratio | 2.45 |
| Total debt/total equity | 0.167 |
|---|---|
| Total debt/total capital | 0.1431 |
More ▼
Growth rates in JPY
Year on year, growth in dividends per share increased 7.14% while earnings per share excluding extraordinary items fell by -3.28%. The positive trend in dividend payments is noteworthy since only some companies in the Chemical Manufacturing industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 2.06% |
|---|---|
| Div growth rate (5 year) | 3.71% |
| Payout ratio (TTM) | 18.34% |
| EPS growth(5 years) | 9.79 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -29.06 |
More ▼
